Letrozole Tablet, Film Coated
Product Images NDC 16729-034

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 16729-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Letrozole (Letrozole 100 Label)

FDA Label Image

Letrozole (Letrozole Carton)

This is a medicine label for Letrozole tablets in unit dose form. It contains information about the manufacturer, dosage, and directions for use. The label cautions to keep the drug out of children's reach and indicates that it is available only by prescription.*

FDA Label Image

Figure 1 Disease-free Survival (median Follow-up 73 Months, Itt Approach) (Letrozole Fig1)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of Time To Progression (tamoxifen Study) (Letrozole Fig2)

FDA Label Image

Figure 3 Survival By Randomized Treatment Arm (Letrozole Fig3)

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Time To Progression (megestrol Acetate Study) (Letrozole Fig4)

FDA Label Image

Figure 5 Kaplan-meier Estimates Of Time To Progression (aminoglutethimide Study) (Letrozole Fig5)

This text is a table showing the time to progression (in days) for a treatment group that received Letrozole tablets at two different doses (0.5mg and 2.5mg). No further context or information is available.*

FDA Label Image

Letrozole Structural Formula (Letrozole Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.